Systematic review with meta-analysis: biologics and risk of infection or cancer in elderly patients with inflammatory bowel disease

Safety of Biologic Therapy in Older Patients with Immune-Mediated Diseases: A Systematic Review and Meta-Analysis

(2019) Nienke Z. Borren et al.   Clinical Gastroenterology and Hepatology

Environmental Risk Factors for Inflammatory Bowel Diseases: an Umbrella Review of Meta-analyses

(2019) Daniele Piovani et al.   GASTROENTEROLOGY

206 – Increased Emergency Department Visits and Hospitalizations for Infectious Diseases in Patients with Elderly-Onset Inflammatory Bowel Disease: A Population-Based Matched Cohort Study

(2019) Ellen Kuenzig et al.   GASTROENTEROLOGY

Inflammatory bowel disease: estimates from the global burden of disease 2017 study

(2019) Daniele Piovani et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Overall and Comparative Risk of Herpes Zoster With Pharmacotherapy for Inflammatory Bowel Diseases: A Nationwide Cohort Study

(2018) Nabeel Khan et al.   Clinical Gastroenterology and Hepatology

Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden

(2018) Åsa H. Everhov et al.   GASTROENTEROLOGY

Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases

(2018) Julien Kirchgesner et al.   GASTROENTEROLOGY

Inflammatory bowel disease in patients over the age of 70 y. Does the disease duration influence its behavior?

(2018) Jose M. Huguet et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Cumulative burden of inflammation predicts colorectal neoplasia risk in ulcerative colitis: a large single-centre study

(2017) Chang-Ho Ryan Choi et al.   GUT

Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease

(2017) Magali Lemaitre et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Crohn's disease

(2017) Joana Torres et al.   LANCET

Ulcerative colitis

(2017) Ryan Ungaro et al.   LANCET

Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease

(2017) Katrina M de Lange et al.   NATURE GENETICS

Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study

(2016) Halima Cheddani et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Crohn’s Disease Activity and Concomitant Immunosuppressants Affect the Risk of Serious and Opportunistic Infections in Patients Treated With Adalimumab

(2016) Mark T Osterman et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Safety of Long-term Treatment With Certolizumab Pegol in Patients With Crohn's Disease, Based on a Pooled Analysis of Data From Clinical Trials

(2016) Edward V. Loftus et al.   Clinical Gastroenterology and Hepatology

Biologic Therapies and Risk of Infection and Malignancy in Patients With Inflammatory Bowel Disease: A Systematic Review and Network Meta-analysis

(2016) Stefanos Bonovas et al.   Clinical Gastroenterology and Hepatology

Efficacy and safety of anti-TNF therapy in elderly patients with inflammatory bowel disease

(2015) T. Lobatón et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Sa1134 Advanced Age Is Not Associated With Lower Safety and Efficacy of Anti-Tumor Necrosis Factor Therapy in the Treatment of Inflammatory Bowel Disease

(2015) Quirine M. van der Vliet et al.   GASTROENTEROLOGY

Comparative Effectiveness of Immunosuppressants and Biologics for Inducing and Maintaining Remission in Crohn's Disease: A Network Meta-analysis

(2015) Glen S. Hazlewood et al.   GASTROENTEROLOGY

Systematic review with meta-analysis: inflammatory bowel disease in the elderly

(2014) J. P. Gisbert et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Oral Corticosteroids and the Risk of Serious Infections in Patients With Elderly-Onset Inflammatory Bowel Diseases

(2014) Paul Brassard et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Biological Agents for Moderately to Severely Active Ulcerative Colitis

(2014) Silvio Danese et al.   ANNALS OF INTERNAL MEDICINE

Association Between Tumor Necrosis Factor-α Antagonists and Risk of Cancer in Patients With Inflammatory Bowel Disease

(2014) Nynne Nyboe Andersen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Risk of malignancies in patients with inflammatory bowel disease treated with thiopurines or anti-TNF alpha antibodies

(2014) Florian Beigel et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Opportunistic Infections With Anti-Tumor Necrosis Factor-α Therapy in Inflammatory Bowel Disease: Meta-Analysis of Randomized Controlled Trials

(2013) Alexander C Ford et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Aging, Cellular Senescence, and Cancer

(2012) Judith Campisi   Annual Review of Physiology

Inflammatory Bowel Disease of the Elderly: Frequently Asked Questions (FAQs)

(2011) Seymour Katz et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Can elderly people be treated safely with anti-TNF agents?

(2011) Vincent Billioud et al.   INFLAMMATORY BOWEL DISEASES

Advanced Age Is an Independent Risk Factor for Severe Infections and Mortality in Patients Given Anti–Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease

(2010) Mario Cottone et al.   Clinical Gastroenterology and Hepatology

Inflammatory Bowel Disease in the Elderly

(2010) Syed Wasif Hussain et al.   DRUGS & AGING

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Risk Factors for Opportunistic Infections in Patients With Inflammatory Bowel Disease

(2008) Murat Toruner et al.   GASTROENTEROLOGY